ProCE Banner Activity

The Role of New HBV Vaccines

Clinical Thought
With more than 20,000 acute hepatitis B cases per year in the United States, here’s my take on how new HBV vaccines might make a difference.

Released: April 14, 2022

Expiration: April 13, 2023

No longer available for credit.

Share

Faculty

Kenneth E. Sherman

Kenneth E. Sherman, MD, PhD

Gould Professor of Medicine
Director, Division of Digestive Diseases
University of Cincinnati College of Medicine
Cincinnati, Ohio

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

VBI Vaccines Inc

Faculty Disclosure

Primary Author

Kenneth E. Sherman, MD, PhD

Gould Professor of Medicine
Director, Division of Digestive Diseases
University of Cincinnati College of Medicine
Cincinnati, Ohio

Kenneth E. Sherman, MD, PhD, has disclosed that he has received consulting fees from Gilead Sciences and Theratechnologies; has received funds for research from AbbVie, Gilead Sciences, and Intercept; and has served on data and safety monitoring boards for Horizon Pharma and Inovio.